Rather than relying on MRI and follow-up biopsy to provide information about a suspect abnormality in the breast, researchers at the Memorial Sloan-Kettering Cancer Center in New York have demonstrated in preliminary trials that NMR spectroscopy could be used to significantly reduce the number of biopsies required to detect the early stages of breast cancer. NMR can lock on to the choline peak associated with malignancy during the MRI scan.
Lia Bartella MD and her colleagues found that NMR could reduce the need for biopsy by 58%. They demonstrated that 23 of 40 suspicious lesions could have been spared biopsy, and none of the resultant cancers would have been missed, in a study group. “All cancers in this study were identified with MR spectroscopy,” explains Bartella, “There were no false-negative results. These results should encourage more women to take this potentially life-saving test.”
More…